Skip to Content

Fidaxomicin Pregnancy and Breastfeeding Warnings

Fidaxomicin is also known as: Dificid

Medically reviewed on June 13, 2017.

Fidaxomicin Pregnancy Warnings

Fidaxomicin has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Fidaxomicin is only recommended for use during pregnancy when benefit outweighs risk.

See references

Fidaxomicin Breastfeeding Warnings

There are no data on the excretion of fidaxomicin into human milk. The manufacturer recommends that caution be used when administering fidaxomicin to nursing women.

See references

References for pregnancy information

  1. "Product Information. Dificid (fidaxomicin)." Optimer Pharmaceuticals, San Diego, CA.

References for breastfeeding information

  1. "Product Information. Dificid (fidaxomicin)." Optimer Pharmaceuticals, San Diego, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide